BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31537894)

  • 1. RNA-based high-risk HPV genotyping and identification of high-risk HPV transcriptional activity in cervical tissues.
    van den Heuvel CNAM; Loopik DL; Ebisch RMF; Elmelik D; Andralojc KM; Huynen M; Bulten J; Bekkers RLM; Massuger LFAG; Melchers WJG; Siebers AG; Leenders WPJ
    Mod Pathol; 2020 Apr; 33(4):748-757. PubMed ID: 31537894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
    Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
    Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
    Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
    Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
    Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
    Lie AK; Kristensen G
    Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
    Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
    Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction.
    Sotlar K; Stubner A; Diemer D; Menton S; Menton M; Dietz K; Wallwiener D; Kandolf R; Bültmann B
    J Med Virol; 2004 Sep; 74(1):107-16. PubMed ID: 15258976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
    Halec G; Schmitt M; Dondog B; Sharkhuu E; Wentzensen N; Gheit T; Tommasino M; Kommoss F; Bosch FX; Franceschi S; Clifford G; Gissmann L; Pawlita M
    Int J Cancer; 2013 Jan; 132(1):63-71. PubMed ID: 22514107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples.
    Wang HY; Kim H; Park S; Park KH; Lee H
    Exp Mol Pathol; 2019 Feb; 106():149-156. PubMed ID: 30605636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip.
    Kim KH; Yoon MS; Na YJ; Park CS; Oh MR; Moon WC
    Gynecol Oncol; 2006 Jan; 100(1):38-43. PubMed ID: 16216319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad-Range Papillomavirus Transcriptome as a Biomarker of Papillomavirus-Associated Cervical High-Grade Cytology.
    Pérot P; Biton A; Marchetta J; Pourcelot AG; Nazac A; Marret H; Hébert T; Chrétien D; Demazoin MC; Falguières M; Arowas L; Laude H; Heard I; Eloit M
    J Mol Diagn; 2019 Sep; 21(5):768-781. PubMed ID: 31416693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted RNA next generation sequencing analysis of cervical smears can predict the presence of hrHPV-induced cervical lesions.
    Andralojc KM; Elmelik D; Rasing M; Pater B; Siebers AG; Bekkers R; Huynen MA; Bulten J; Loopik D; Melchers WJG; Leenders WPJ
    BMC Med; 2022 Jun; 20(1):206. PubMed ID: 35676700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.